USANA Health Sciences, Inc. Annual report [Section 13 and 15(d), not S-K Item 405]

Annual report [Section 13 and 15(d), not S-K Item 405]

Common Stock and Earnings Per Share

Common Stock and Earnings Per Share

12 Months Ended

Dec. 28, 2024

COMMON STOCK AND EARNINGS PER SHARE

Basic earnings per share (“EPS”) are based on the weighted-average number of shares outstanding for each period. Shares that have been repurchased and retired during the periods specified below have been included in the calculation of the number of weighted-average shares that are outstanding for the calculation of basic EPS based on the time they were outstanding in any period. Diluted EPS are based on shares that are outstanding (computed under basic EPS) and on potentially dilutive shares. Shares that are included in the diluted EPS calculations under the treasury stock method include equity awards that are in-the-money but have not yet been exercised.

The following is a reconciliation of the numerator and denominator used to calculate basic EPS and diluted EPS for the periods indicated:


	Year Ended
	2024		2023		2022
Net earnings attributable to USANA	$	42,030	$	63,788	$	69,350
Weighted average common shares outstanding - basic	19,103		19,250		19,254
Dilutive effect of in-the-money equity awards	59		95		56
Weighted average common shares outstanding - diluted	19,162		19,345		19,310
Earnings per common share from net earnings attributable to USANA:
Basic	$	2.20	$	3.31	$	3.60
Diluted	$	2.19	$	3.30	$	3.59

Equity awards for the following shares were not included in the computation of diluted EPS attributable to USANA due to the fact that their effect would be anti-dilutive:


Year Ended
2024	2023	2022
567	319	354

During the years ended 2024 and 2023, the Company repurchased and retired 194 shares for $9,483 including accrued excise tax of $39, and 180 shares for $11,653 including accrued excise tax of $54, respectively. During the year ended 2022, the Company repurchased and retired 288 shares for an aggregate price of $25,382.